Skip to content

Arm-hand Boost Program During Inpatient Rehabilitation After Stroke

Arm-hand Boost Program During Inpatient Rehabilitation After Stroke: Pilot Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04584177
Enrollment
20
Registered
2020-10-12
Start date
2019-05-09
Completion date
2020-11-03
Last updated
2021-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

A pilot cross-over RCT including participants with sub-acute stroke is conducted in an inpatient rehabilitation setting. The experimental group (EG) receives an arm-hand boost program on top of their usual care program. The control group (CG) receives a dose-matched program of strengthening exercises for the lower limbs and general reconditioning. After 4 weeks, a cross-over is performed. Before, after 4 weeks and after 8 weeks of additional therapy, different clinical outcome measures for the upper limb are administered.

Interventions

BEHAVIORALArm-hand BOOST program

The arm-hand boost program is provided 1 hour/day, 5x/week for 4 weeks, on top of their usual care program. The focus of the boost program is on scapula-setting, core-stability when reaching, movements with 30-60° flexion/abduction in shoulder, fine manipulation and integration in complex ADL tasks. Additionally, patients exercise 1 hour per week using the Armeo Power (Hocoma). Therefore, the additional arm-hand boost program consists of 24 one-hour sessions, provided over four weeks.

BEHAVIORALControl program

A dose-matched program of strengthening exercises for the lower limbs and general reconditioning

Sponsors

Jessa Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* first stroke, as defined by WHO, * minimal stay of 4 weeks in inpatient setting at study start * minimally 18 years old * being able to sit independently (trunk control test, item 3 = 25), * motor impairment in the upper limb (Fugl-Meyer assessment, stage 2 (synergies): 8-17p, or stage 2: \<8p combined witht stage 5 (hand): \>6p * sufficient cooperation to perform intervention and evaluations

Exclusion criteria

* musculoskeletal and/or other neurological impairments with permanent damage that may hinder the study * subdural hematoma, tumor, encephalitis, trauma, or other that lead to similar symptoms as stroke * severe communication, cognitive or language impairments that hinder the investigations * no written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change from Fugl-Meyer Assessment-Upper Extremity at 4 weeksBetween baseline and first 4 weeks of studyUL assessment - Function
Change from Fugl-Meyer Assessment-Upper Extremity at 8 weeksBetween baseline and end of study (=8 weeks)UL assessment - Function
Change from Action Research Arm Test at 4 weeksBetween baseline and first 4 weeks of studyUL Assessment - Activities
Change from Action Research Arm Test at 8 weeksBetween baseline and end of study (=8 weeks)UL Assessment - Activities

Secondary

MeasureTime frameDescription
Change from Stroke upper limb capacity scale (SULCS) at 4 weeksBetween baseline and first 4 weeks of studyUL Assessment - Activities
Change from Stroke upper limb capacity scale (SULCS) at 8 weeksBetween baseline and end of study (=8 weeks)UL Assessment - Activities
Change from Jebsen Taylor hand function test at 4 weeksBetween baseline and first 4 weeks of studyUL Assessment - Activities
Change from Box & Block test at 8 weeksBetween baseline and end of study (=8 weeks)UL Assessment - Activities
Change from Box & Block test at 4 weeksBetween baseline and first 4 weeks of studyUL Assessment - Activities
Change from Jebsen Taylor hand function test at 8 weeksBetween baseline and end of study (=8 weeks)UL Assessment - Activities
Change from Rivermead Motor Assessment Arm function at 4 weeksBetween baseline and first 4 weeks of studyUL Assessment - Activities
Change from Rivermead Motor Assessment Arm function at 8 weeksBetween baseline and end of study (=8 weeks)UL Assessment - Activities

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026